| Date: |
2009-03-05 |
| Type: |
Newsletter |
| Organizer: |
SABPA |
| Location: |
San Diego |
| Source: |
SABPA |
|
|
|
|
1. SABPA 2nd Entrepreneur Symposium Report (02/21/09)
2. SABPA7th Science & Technology Forum (San Diego Chapter, 03/21/09)
3. SABPA 4th Biomedical Forum (OC/LA Chapter, 03/28/09)
4. Community Events
1. 2nd SABPA Entrepreneur Symposium Report (02/21/09)
On Saturday, Feb. 21st about 100 people attended 2nd SABPA Entrepreneur Symposium and had a very pleasant evening. Dr. Sankey gave an excellent talk about how to start a biotech company from a VC’s perspective. The audience had very active communications with Dr. Dankey throughout his presentation and Q&A. Many thanks to Hai Wang, Jingjing Ye, Yinong Xie, Shuyan Lu, James Zhao, Wei-Wei Zhang, Sam Chen and many other volunteers to make this event successful.
For presentation slides, please check this web page.
The 3rd SABPA Entrepreneur Symposium will be held at 5 pm on May 16 at The Institute of Americas, UCSD. The speaker is Dr. Magda Marquet, Co-founded of Althea Technologies. The title of her presentation is “Challenges and opportunities of a bioentrepreneur in today's economic climate: The story of Althea technologies”
2. SABPA Science & Technology Forum VII (San Diego Chapter, 03/21/09)
Biomarker, Pharmacogenomics and Personalized Medicine
Date: March 21, 2009 (Saturday)
Location: Institute of Americas, UCSD (here is the directions)
Registration: $20 for online registration, $10 for students and post-docs, $40 for on-site registration, online registration ends March 19, 2009
Corporate Annual Pass Package:
$500 for 20 passes good for any of the SABPA events over the next 12 months.Please contact: Feng Tian for this package
Pharmaceutical industry has been operating under the paradigm of “one drug fits all” for many decades. However, few drugs offer universal efficacy in all the patient population, and some even cause serious adverse effects in certain patient groups. These obstacles, in addition to the tougher FDA review standards and rapidly evaporating pipelines, have put unprecedented challenges on the drug industry, and inevitably push the industry to make increasing shift towards “the right drug to the right patient”, i.e. personalized medicine. The topic of SABPA Science & Technology Forum VII will focus on recent advances in the development of biomarkers, pharmacogenomics and personalized medicine. Experts from both the academia and industry will present overviews as well as specific examples of identifying novel genomic biomarkers, predicting drug efficacy and adverse effects, and using modern technologies such as high density microarray technology, genome-wide RNA expression profiling and DNA genotyping. These approaches are poised to dramatically shorten the drug development cycle, improve drug efficacy and safety, and ultimately deliver the right medicines tailored to the right patients.
Confirmed speakers & presentations
Nicholas J. Schork, Ph.D.
Director of Research, Scripps Genomic Medicine, Director of Biostatistics and Bioinformatics, The Scripps Translational Science Institute
Genetic Variation, Association Studies, and Personalized Medicine
Dominic Spinella, Ph.D.
Executive Director, Translational and Molecular Medicine, Pfizer Biotechnology and Bio-innovation Center (BBC)
Personalized Medicine: Practical Considerations for Drug Development
Wen Luo, Ph.D.
Research Investigator, New Leads Discovery, Ligand Pharmaceuticals
Applying genomic biomarkers to predict drug response: Rescue a phase III cancer drug with a genome-wide pharmacogenomic study
Dominic Eisinger, Ph.D.
Director, Strategic Development, Rules Based Medicine
Disease Related Protein Biomarker Profiles: Successful Strategies And Applications In Drug Development And Diagnostics
Michael Nerenberg, M.D.
Sr VP for Med. Affairs, Business Development and CTO, Genoptix, Inc.
Practical aspects of adoption of Personalized Medicine in Oncology
Carl Hull
Vice President, UNIConnect LC
A Genealogical Approach to Create Personalized Software for Personalized Medicine
Due to the recent economic crisis, there has been a large number of lay-offs in San Diego biotech. To help our members and the biotech community, SABPA will set up a job fair at the Forum simultaneously. We have invited recruiters and biotech companies who have active job openings to set up tables at the forum as a free service to our members and recruiters. We hope the job fair will provide the opportunity for our members who are looking for jobs to talk directly with the recruiters and biotech companies.
3. SABPA 4th Annual Biomedical Forum (OC/LA Chapter, 03/28/09)
Date/Time: March 28, 2009 (Saturday); 8:30 AM – 4:00 PM
Location: McDonnell Douglas Auditorium, UC Irvine
Registration (Lunch included): $30 for pre-registration (before March 14), $15 for students and post-docs, $40 for onsite registration
Click here for online registration.
The upcoming annual biomedical forum will focus on the latest innovations in medical devices and biotechnology/pharmaceutical industries and business opportunities to thrive in the new economy amid global financial challenges. The mission of this forum is to provide an attractive platform for entrepreneurs, scientists, engineers, investors, executives, and policy makers to promote life sciences, biotechnology, pharmaceutical, medical device and alliances across the biomedical industry in Southern California and Asia. The annual biomedical forum is one of the flagship events organized by SABPA OC/LA, which consistently attracted more than 200 attendees.
Program
Mitchell Brin, M.D., Senior Vice President, Global Drug Development & Chief Scientific Officer, Allergan, LLC. & Clinical Professor of Neurology, University of California, Irvine
“The Development of BOTOX”
David Ke, M.D., Executive Scientific Director, Amgen, Inc.
“Transforming Basic Science To Drug Discovery: The Story Of Sclerosteosis And Development Of Anti-Sclerostin Monoclonal Antibody”
James Shen Ph.D., Import Compliance Officer, FDA
“Requirements Of Laws And Regulations Enforced By FDA Concerning Medical And Pharmaceutical Products”
Stan Rowe, Chief Scientific Officer, Corporate Vice President, Edwards Lifesciences LLC
“Practical Innovations in Cardiac Disease Management”
Peter Chen, Ph.D., President, Center for Innovation and Strategic Collaboration, St. Jude Medical, Inc.
“Innovations in Cardiac Rhythm Management and Neuromodulation Devices”
Rob Michiels, Chief Operating Officer, CoreValve Inc.
“Transformation in Heart Valve Replacement”
Sofie Qiao, Ph.D., Founder, Senior VP, Director of Chinese Operations, Lead Therapeutics, Inc
"The Long LEAD to Venture Funding"
Daren Chen, J.D., MBA, Hillcrest Venture Partners
“Investment Criteria in the New Global Economy”
Cliff Guan, Senior Manager, International Tax – China Desk Leader, Pacific Southwest Region, Deloitte Tax LLP
“Business Landscape In US And China: Practical And Effective Tax Strategies"
4. Community Events
ACS Career Development Workshop IV:
Networking Skills
The ACS San Diego Section’s Professional Development Committee will host its first 2009 seminar, Networking Skills. Three local experts will present their perspective and share their experiences in networking. Their presentations and panel discussions will shed light on what networking is all about, how and why to network, what to expect from it, and Internet tools that aid networking. They will also be available to discuss local networking events.
DATE: Wednesday, March 18, 2009
TIME: 5:30 pm to 8:30 pm (light dinner provided)
PLACE: Morrison & Foerster, LLP
12531 High Bluff Drive, Suite 100
San Diego, CA 92130
SPEAKERS:
Dr. Zhu Shen CEO, BioForesight
Victoria Tucker Managing Director, ZeroBoundary, Inc.
Peggy Wallace Founder, Making Conversation
PROGRAM:
5:30 – 6:30 pm Dinner and networking
6:30 – 7:30 pm Presentations
7:30 – 8:30 pm Panel discussion, Q&A
FEE: Free and open to the public, but reservations are required
RSVP to: Dr. Mingzhu Zhang, mzzhang@medicilon.com by Friday, March 13, 2009
PROGRAM UPDATES: See http://www.sandiegoacs.org
|
|
